Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $9.0700 (7.34%) ($7.6600 - $9.5800) on Thu. Feb. 27, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.82% (three month average) | RSI | 55 | Latest Price | $9.0700(7.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -3% a day on average for past five trading days. | Weekly Trend | CGEN advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(67%) ARKK(64%) XBI(64%) IBB(58%) IBUY(56%) | Factors Impacting CGEN price | CGEN will decline at least -1.91% in a week (0% probabilities). VXX(-37%) VIXM(-34%) UUP(-12%) TLT(-4%) SHY(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.91% (StdDev 3.82%) | Hourly BBV | 0 () | Intraday Trend | 11.7% | | | |
|
5 Day Moving Average | $9.14(-0.77%) | 10 Day Moving Average | $9.3(-2.47%) | 20 Day Moving Average | $8.82(2.83%) | To recent high | -13.7% | To recent low | 69.5% | Market Cap | $750m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |